Ali Saeidi

Director of Product Development

Therapeutic Areas

Drug	Indication	Phase
Lab-on-Skin Platform for Organ Dysfunction	Early detection of organ dysfunction (e.g., sepsis) in critical care, oncology, and post-surgical patients	Pre-clinical/Development